AbelZeta Inc.
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| C-CAR168 CAR T-Cell Therapy for the Treatment of Lupus Nephritis Refractory to Standard Therapy (NCT07729826) | AbelZeta Inc. | 2026-09-30 |
| C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease (NCT06935474) | AbelZeta Inc. | 2026-07-01 |
| C-TIL051 in Non-Small Cell Lung Cancer (NCT05676749) | AbelZeta Inc. | 2024-02-29 |
Track AbelZeta Inc. automatically
Every clearance here is in the API, with alerts when new ones post.